FDA Announces Proposed Collection of Information for Postmarketing Safety Reports Under Paperwork Reduction Act Review

Summary

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. The FDA is seeking public comment on electronic submission requirements for postmarketing safety reports for human drug and biological products.